echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Nat Med: Risk of myocarditis, pericarditis and arrhythmia associated with COVID-19 vaccination or SARS-CoV-2 infection

    Nat Med: Risk of myocarditis, pericarditis and arrhythmia associated with COVID-19 vaccination or SARS-CoV-2 infection

    • Last Update: 2021-12-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Although no adverse events such as myocarditis and pericarditis were observed in the 2019 coronavirus disease ( COVID-19 ) vaccine trial, there have been a large number of reports of suspected myocarditis and pericarditis cases after vaccination in the general population


    COVID-19

    Recently, a research article was published in the top medical journal Nature Medicine.


    Arrhythmia

    The researchers found that 1-28 days after vaccination and after testing positive for SARS-CoV-2, the risk of myocarditis associated with the first dose of ChAdOx1 and BNT162b2 vaccine and the first and second doses of mRNA-1273 vaccine increased


    In contrast, within 28 days of testing positive for SARS-CoV-2, an additional 40 (95% CI 38-41) myocarditis events occurred per million patients


    It can be seen that, except for the increased risk of arrhythmia after the second dose of mRNA-1273 vaccine, no similar association has been observed in any COVID-19 vaccine


    Except for the increased risk of arrhythmia after the second dose of mRNA-1273 vaccine, no similar association has been observed in any COVID-19 vaccine


    Original source:

    Martina Patone,et al.


    Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection

    in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.